The serum is prepared by Rehovot-based biopharmaceutical company Kamada.

Three patients have already received the serum and are doing well, according to Dr. Yaron Ilan, chief of internal medicine at Hadassah University Medical Center. "The first patient demonstrated a rapid clinical benefit and went home after previously being in moderate condition."

The other two also have been released from the hospital.

Ilan stressed that this experimental treatment, though very encouraging, is in an early phase.

Dr. Zeev Rotstein, director general of Hadassah Medical Center, called their recovery "almost a miracle."

Rotstein was among the initiators of the collection of plasma from recovered corona patients. He also revealed to the Jerusalem Post on August 12 that Hadassah will help test a Russian-developed vaccine for coronavirus.

For the past three months, Hadassah has been collecting plasma donations from recovered patients with the cooperation of ultra-Orthodox communal organizations.

Kamada said additional Israeli hospitals are taking part in this Phase 1/2 clinical trial of the anti-SARS-CoV-2 plasma-derived IgG.

"This open-label, single-arm multicenter study was approved by the Ministry of Health in Israel. The trial will assess the safety, pharmacokinetics and pharmacodynamics of the company's plasma-derived IgG product in hospitalized, non-ventilated Covid-19 patients with pneumonia," Kamada reported.

"A total of 12 eligible patients will be enrolled and receive Kamada's product at a single dose of 4g within 10 days of initial symptoms. Patients will be followed for 84 days. In parallel, Kamada intends to further explore the potential of its IgG product to prevent Covid-19 disease in healthy subjects at risk in a separate study."

This milestone is part of the global collaboration agreement established in April 2020 between Kamada and its partner Kedrion Biopharma for the development, manufacturing and distribution of a plasma-derived immunoglobulin product as a potential treatment for coronavirus disease.

Kamada and Kedrion intend to conduct a pre-investigational new drug (IND) meeting with the U.S. Food and Drug Administration soon in anticipation of obtaining FDA approval of the proposed clinical development program. Meanwhile, Kedrion will collect Covid-19 convalescent plasma from recovered American patients.

"We are encouraged by the results of the product neutralization activity and we believe our product has the potential to be an effective treatment for hospitalized, non-ventilated COVID-19 patients with pneumonia, and look forward to the results from this trial," said Amir London, Kamada's CEO. Subscribe for free to Breaking Christian News here

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

'Young Washington' Delivers Record Opening Weekend for Angel Studios

After an Emotional Loss to Belgium, the US Men's Team Continued to Give God the Glory

A 'Miracle': CCP Releases Pastor Ezra Jin

House Speaker Johnson Braces for a High-Stakes July with Everything on the Line

Why the NATO Summit in Ankara Matters to the US

New Report Details Secret Service Failures in Butler Assassination Attempt

Charlie Kirk's Family Faces Accused Killer Tyler Robinson for the First Time as Murder Case Moves Forward

'The Passion of the Christ' Getting Theatrical Re-Release Ahead of Highly Anticipated Sequel

A Sweet Update on That Oregon Couple Who Stepped Up at the Great American State Fair

The World Lights Up for America's 250th, While the American Left Opts to Whine About It

The America 250 Celebration in DC Was One for the History Books (Videos)

Must Watch: Katharine Birbalsingh's Fiery ARC Speech-How Schools Are Destroying the Moral Core of the West (Video)

DHS Condemns Minnesota Pardon of Convicted Child Rapist

The President Rings NYSE Opening Bell from the Oval Office, While Officially Launching the Trump Accounts for Children

Venezuelan Earthquake Death Toll Soars as Country's Independence Day Arrives

July 4th Fireworks Will Be Great on America's 250th Birthday, But Your Dog Will Hate Them!

Our Favorite Patriotic Tunes, Part 2: 3 Songs Swiped from the Brits (Videos)

World Cup: Team USA Wins, Goes to the Sweet 16 Round against Belgium on Monday

3,000 Walk Boston's Freedom Trail: 'We Have A Lot to Thank God For'

Except for Democrats, a New Survey Shows Americans Still DO Have Pride in Their Country (And We Don't Mean the LGBT Kind)